A first-of-its-kind open-source, reproducible analysis platform for pediatric brain tumors has been developed in collaboration by researchers. Researchers have used this platform to identify preliminary findings about genetic variants linked to poorer outcomes that may help direct future diagnostic and therapeutic advancements with the aid of thousands of genomically sequenced samples.